Page last updated: 2024-08-25

dexrazoxane and Soft Tissue Neoplasms

dexrazoxane has been researched along with Soft Tissue Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busemann, C; Ehninger, G; Gerdes, S; Hentschel, L; Kopp, HG; Lenz, F; Pink, D; Reichardt, P; Richter, S; Schuler, MK; West, A1

Other Studies

1 other study(ies) available for dexrazoxane and Soft Tissue Neoplasms

ArticleYear
Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.
    BMC cancer, 2016, 08-09, Volume: 16

    Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Dexrazoxane; Disease-Free Survival; Female; Free Radical Scavengers; Heart; Humans; Male; Middle Aged; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Young Adult

2016